Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1994 May;93(5):2168–2174. doi: 10.1172/JCI117213

Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.

E E Powell 1, P A Kroon 1
PMCID: PMC294355  PMID: 8182149

Abstract

The liver plays a key regulatory role in cholesterol metabolism. Two proteins are central in this role; the LDL receptor and 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA reductase), the rate-limiting enzyme in cholesterol biosynthesis. In the current investigation, we have used a sensitive nonradioactive method to study the regulation of LDL receptor and HMG CoA reductase mRNA levels in liver biopsy samples and freshly isolated mononuclear leukocytes from 13 patients who underwent cholecystectomy for gallstones. mRNA copy numbers were determined by PCR amplification of reverse-transcribed RNA using synthetic RNA as an internal standard. Incorporation of digoxigenin-11-dUTP during amplification allowed direct detection and quantitation of mRNA levels by chemiluminescence. These experiments showed that the average number of LDL receptor mRNA molecules in liver (21 +/- 3 x 10(4)/micrograms of RNA) and mononuclear leukocytes (24 +/- 3 x 10(4)/micrograms of RNA) are indistinguishable, whereas the number of HMG CoA reductase molecules in liver (107 +/- 15 x 10(4)/micrograms of RNA) is smaller than that in mononuclear leukocytes (158 +/- 21 x 10(4)/micrograms of RNA, P < 0.05). These numbers correspond to an average of 1-6 copies of LDL receptor mRNA and 5-42 copies of HMG CoA reductase mRNA per cell. There was a significant correlation between the numbers of LDL receptor (P = 0.0005) and HMG CoA reductase (P = 0.003) mRNA molecules in liver and mononuclear leukocytes. Furthermore, the numbers of copies of HMG CoA reductase and LDL receptor mRNA were correlated with each other in both liver (P = 0.02) and mononuclear leukocytes (P = 0.01), consistent with coordinate regulation. These data demonstrate that the mechanisms which regulate mRNA levels in liver and mononuclear cells are similar and suggest that freshly isolated mononuclear cells can be used to predict HMG CoA reductase and LDL receptor mRNA levels in liver.

Full text

PDF
2168

Images in this article

2170Image
on p.2170
2171Image
on p.2171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerlund J. E., Reihnér E., Angelin B., Rudling M., Ewerth S., Björkhem I., Einarsson K. Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology. 1991 Apr;100(4):1046–1053. doi: 10.1016/0016-5085(91)90281-o. [DOI] [PubMed] [Google Scholar]
  2. Allen J. K., Hensley W. J., Nicholls A. V., Whitfield J. B. An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem. 1979 Feb;25(2):325–327. [PubMed] [Google Scholar]
  3. Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986 Apr 4;232(4746):34–47. doi: 10.1126/science.3513311. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Cai H. J., Xie C. L., Chen Q., Chen X. Y., Chen Y. H. The relationship between hepatic low-density lipoprotein receptor activity and serum cholesterol level in the human fetus. Hepatology. 1991 May;13(5):852–857. [PubMed] [Google Scholar]
  6. Cuthbert J. A., Russell D. W., Lipsky P. E. Regulation of low density lipoprotein receptor gene expression in human lymphocytes. J Biol Chem. 1989 Jan 15;264(2):1298–1304. [PubMed] [Google Scholar]
  7. Egusa G., Beltz W. F., Grundy S. M., Howard B. V. Influence of obesity on the metabolism of apolipoprotein B in humans. J Clin Invest. 1985 Aug;76(2):596–603. doi: 10.1172/JCI112011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature. 1990 Feb 1;343(6257):425–430. doi: 10.1038/343425a0. [DOI] [PubMed] [Google Scholar]
  9. Harwood H. J., Jr, Bridge D. M., Stacpoole P. W. In vivo regulation of human mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase. Studies in normal subjects. J Clin Invest. 1987 Apr;79(4):1125–1132. doi: 10.1172/JCI112928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kesäniemi Y. A., Beltz W. F., Grundy S. M. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest. 1985 Aug;76(2):586–595. doi: 10.1172/JCI112010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kroon P. A., Powell E. E. Liver, lipoproteins and disease: I. Biochemistry of lipoprotein metabolism. J Gastroenterol Hepatol. 1992 Mar-Apr;7(2):214–224. doi: 10.1111/j.1440-1746.1992.tb00965.x. [DOI] [PubMed] [Google Scholar]
  12. Le Cras T. D., Gherardi E., Bowyer D. E. A sensitive RNase protection assay for the quantitation of the mRNAs for the LDL receptor and HMG-CoA reductase in human total RNA. Effects of treatments on cells in culture designed to up- and down-regulate expression of the LDL receptor. Atherosclerosis. 1991 Sep;90(1):81–90. doi: 10.1016/0021-9150(91)90246-y. [DOI] [PubMed] [Google Scholar]
  13. Ma P. T., Yamamoto T., Goldstein J. L., Brown M. S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci U S A. 1986 Feb;83(3):792–796. doi: 10.1073/pnas.83.3.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mistry P., Miller N. E., Laker M., Hazzard W. R., Lewis B. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J Clin Invest. 1981 Feb;67(2):493–502. doi: 10.1172/JCI110058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Molowa D. T., Cimis G. M. Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells. Biochem J. 1989 Jun 15;260(3):731–736. doi: 10.1042/bj2600731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Powell E. E., Kroon P. A. Measurement of mRNA by quantitative PCR with a nonradioactive label. J Lipid Res. 1992 Apr;33(4):609–614. [PubMed] [Google Scholar]
  17. Reihnér E., Rudling M., Ståhlberg D., Berglund L., Ewerth S., Björkhem I., Einarsson K., Angelin B. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990 Jul 26;323(4):224–228. doi: 10.1056/NEJM199007263230403. [DOI] [PubMed] [Google Scholar]
  18. Rudling M. Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res. 1992 Apr;33(4):493–501. [PubMed] [Google Scholar]
  19. Schneider W. J., Beisiegel U., Goldstein J. L., Brown M. S. Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem. 1982 Mar 10;257(5):2664–2673. [PubMed] [Google Scholar]
  20. Sorci-Thomas M., Wilson M. D., Johnson F. L., Williams D. L., Rudel L. L. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol. J Biol Chem. 1989 May 25;264(15):9039–9045. [PubMed] [Google Scholar]
  21. Soutar A. K., Harders-Spengel K., Wade D. P., Knight B. L. Detection and quantitation of low density lipoprotein (LDL) receptors in human liver by ligand blotting, immunoblotting, and radioimmunoassay. LDL receptor protein content is correlated with plasma LDL cholesterol concentration. J Biol Chem. 1986 Dec 25;261(36):17127–17133. [PubMed] [Google Scholar]
  22. Spady D. K., Turley S. D., Dietschy J. M. Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. J Lipid Res. 1985 Apr;26(4):465–472. [PubMed] [Google Scholar]
  23. Tall A. R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 1990 Aug;86(2):379–384. doi: 10.1172/JCI114722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717–9721. doi: 10.1073/pnas.86.24.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Williams D. L., Newman T. C., Shelness G. S., Gordon D. A. Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes. Methods Enzymol. 1986;128:671–689. doi: 10.1016/0076-6879(86)28099-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES